Ontology highlight
ABSTRACT:
SUBMITTER: Wang Y
PROVIDER: S-EPMC7496722 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
Wang Yuwen Y Zou Songyun S Zhao Zhuyun Z Liu Po P Ke Changneng C Xu Shi S
Cell biology international 20200418 8
Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cancer cases; however, it is characterized by easy relapse and low survival rate, leading to one of the most intractable diseases in clinical practice. Despite decades of basic and clinical research, little progress has been made in the management of SCLC. The current standard first-line regimens of SCLC still remain to be cisplatin or carboplatin combined with etoposide, and the adverse events of chemotherapy are by no means n ...[more]